Bill Text: FL S1604 | 2012 | Regular Session | Introduced
Bill Title: Prescription Drug Monitoring Program
Spectrum: Partisan Bill (Republican 1-0)
Status: (Failed) 2012-03-09 - Died in Health Regulation [S1604 Detail]
Download: Florida-2012-S1604-Introduced.html
Florida Senate - 2012 SB 1604 By Senator Fasano 11-00920B-12 20121604__ 1 A bill to be entitled 2 An act relating to the prescription drug monitoring 3 program; amending s. 893.055, F.S.; providing that 4 when a controlled substance listed as a Schedule II 5 substance is dispensed or released, in addition to 6 other identification procedures, a fingerprint may be 7 collected; providing exceptions; conforming 8 provisions; providing an effective date. 9 10 Be It Enacted by the Legislature of the State of Florida: 11 12 Section 1. Subsection (14) of section 893.055, Florida 13 Statutes, is amended to read: 14 893.055 Prescription drug monitoring program.— 15 (14)(a) A pharmacist, pharmacy, or dispensing health care 16 practitioner or his or her agent, before releasing a controlled 17 substance to any person not known to such dispenser, shall 18 require the person purchasing, receiving, or otherwise acquiring 19 the controlled substance to present valid photographic 20 identification or other verification of his or her identity to 21 the dispenser. If the person does not have proper 22 identification, the dispenser may verify the validity of the 23 prescription and the identity of the patient with the prescriber 24 or his or her authorized agent. Verification of health plan 25 eligibility through a real-time inquiry or adjudication system 26 will be considered to be proper identification.This subsection27does not apply in an institutional setting or to a long-term28care facility, including, but not limited to, an assisted living29facility or a hospital to which patients are admitted.As used 30 in this paragraphsubsection, the term “proper identification” 31 means an identification that is issued by a state or the Federal 32 Government containing the person’s photograph, printed name, and 33 signature or a document considered acceptable under 8 C.F.R. s. 34 274a.2(b)(1)(v)(A) and (B). 35 (b) When a controlled substance listed as a Schedule II 36 substance under s. 893.03 is dispensed or released, in addition 37 to the identification procedures in paragraph (a), the 38 pharmacist, pharmacy, or dispensing health care practitioner or 39 his or her agent may obtain from the person receiving the 40 controlled substance a right thumbprint or a fingerprint from 41 another digit if the person has no right thumb. 42 (c) This subsection does not apply in an institutional 43 setting or to a long-term care facility, including, but not 44 limited to, an assisted living facility or hospital to which 45 patients are admitted. 46 Section 2. This act shall take effect July 1, 2012.